06 July 2019 : Case report
Safety of an Abbreviated Transition Period When Switching From Intravenous Immunoglobulin to Eculizumab in Patients with Treatment-Refractory Myasthenia Gravis: A Case Series
Unusual setting of medical care
DOI: 10.12659/AJCR.916424
Am J Case Rep 2019; 20:965-970
HTML version available soon